OZEMvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with OZEM, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
OZEM performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/28/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | OZEM ETF 2 | +0.15%– | +6.60%– | -4.17%– | +24.59%– | n/a– | n/a– |
| Flows | OZEM ETF 2 | +$10M– | +$9M– | +$22M– | +$22M– | -– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | OZEM ETF 2 | +21.48%– | +22.70%– | n/a– | n/a– |
| Max drawdown | OZEM ETF 2 | -6.63%– | -19.51%– | n/a– | n/a– |
| Max drawdown duration | OZEM ETF 2 | 51d– | 183d– | n/a– | n/a– |
Trading data
OZEM | ETF 2 | |
Last sale 7/29/2026 at 1:30 PM | $32.66 | – |
| Previous close 07/28/2026 | $32.81 | – |
| Consolidated volume 07/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/29/2026 at 1:30 PM
Live
Closed
OZEM | ETF 2 | |
|---|---|---|
| Last price | $32.66 | – |
| 1D performance | -0.46% | – |
| AuM | $63.07 M | – |
| E/R | 0.59% | – |
Characteristics
OZEM | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Roundhill Investments | – |
| Benchmark | - | – |
| N° of holdings | 24 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | May 21, 2024 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
OZEM
USA
44.42%
Denmark
19.13%
China
16.37%
Other
20.08%
ETF 2
Sectors
OZEM
Healthcare
99.56%
Other
0.44%
ETF 2
Advertisement
Diversification
OZEM
Total weight of top 15 holdings out of 15
82.24%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
OZEM
Novo Nordisk A/S
13.29%
Eli Lilly & Co.
13.07%
Pfizer Inc.
6.58%
Kailera Therapeutics, Inc.
6.00%
Viking Therapeutics, Inc.
5.84%
CSPC Pharmaceutical Group Ltd.
5.22%
Chugai Pharmaceutical Co., Ltd.
4.53%
Ascletis Pharma, Inc.
3.95%
Zealand Pharma A/S
3.93%
AstraZeneca PLC
3.89%
Amgen, Inc.
3.89%
Hanmi Pharmaceutical Co., Ltd.
3.33%
Roche Holding AG
3.12%
Structure Therapeutics, Inc.
2.89%
MBX Biosciences, Inc.
2.71%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about OZEM
Advertisement
Advertisement
